Clinical Trials Logo

Filter by:
NCT ID: NCT05763043 Not yet recruiting - Clinical trials for Obstetric Labor Complications

Monoferric for Prenatal Iron Deficiency

Start date: November 2023
Phase: Early Phase 1
Study type: Interventional

A prospective observational study of pregnant women with iron deficiency anemia and oral iron intolerance or advanced gestational age.

NCT ID: NCT05763030 Not yet recruiting - Child Sleep Clinical Trials

Sleep Promotion Intervention in Bangladesh

Start date: April 2027
Phase: N/A
Study type: Interventional

Using a pragmatic cluster randomized trial, this study aims to examine the feasibility and acceptability of a 3-week behavioral sleep intervention and to test the preliminary efficacy of the intervention compared to a wait-list control with children ages 2-3 years old at two Early Learning Centers on preschooler's sleep health in Dhaka, Bangladesh.

NCT ID: NCT05762718 Not yet recruiting - Not Determined Clinical Trials

Validation of a Food Frequency Questionnaire: VioScreen

Start date: June 2023
Phase:
Study type: Observational

The purpose of this study is to learn more about how well a questionnaire about food intake works. The study team will compare questionnaire responses to several other measurements of food intake. There is a special emphasis on fruit and vegetable intake.

NCT ID: NCT05762705 Not yet recruiting - HIV/AIDS Clinical Trials

A Mobile Gaming App to Improve Adherence to PrEP

Start date: June 1, 2024
Phase: N/A
Study type: Interventional

In this study, the investigators will test the mobile game, Viral Combat, for efficacy and acceptability among diverse participants, ages 15-34 years, receiving PrEP care in clinical settings in New England and Mississippi. Formative evaluation interviews will be conducted with stakeholders (healthcare workers, clinic administrators, and patients taking PrEP) to inform intervention delivery. Data from the formative interviews will also be used to make necessary adaptations to the game and assess acceptability for diverse populations and clinics. Viral Combat will then be further tested with 200 participants ages 15-34 years, receiving PrEP care at clinical sites in the South (n=100 Jackson, MS) and New England (n=100, Providence, RI; Boston, MA) in a multisite Hybrid Type 1 effectiveness-implementation randomized controlled trial (RCT). This trial will test the efficacy of the intervention compared to a control condition (a non-PrEP related game) on biological and behavioral measures. At the end of the trial, a summative evaluation of the implementation context using the i-PARIHS framework will occur. These interviews with study participants and clinic staff will inform future implementation and dissemination of Viral Combat.

NCT ID: NCT05761925 Not yet recruiting - Coma Clinical Trials

The COMA Family Program: A Skills-Based Resiliency Program for Caregivers of Patients With Severe Acute Brain Injuries

COMA-F
Start date: January 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to pilot a psychosocial skills-based intervention for caregivers of patients with severe acute brain injuries. The data the investigators gather in this study will be used to further refine our COMA-F intervention.

NCT ID: NCT05761197 Not yet recruiting - Clinical trials for Early Childhood Caries

Oropharyngeal Candidiasis (OPC) and S-ECC

Oral-Thrush
Start date: July 1, 2024
Phase:
Study type: Observational

The overall objective of this study is to investigate the association of early Candida infection (known as oral thrush or oropharyngeal candidiasis, OPC) in children during the first year of life with the onset and severity of severe early childhood caries (S-ECC).

NCT ID: NCT05760898 Not yet recruiting - Hypertension Clinical Trials

Reducing Hypertension Disparities in Rheumatoid Arthritis

Start date: August 1, 2024
Phase: N/A
Study type: Interventional

Rheumatoid arthritis (RA) is a autoimmune disease associated with an increased risk of developing coronary artery disease (CAD) and premature death, particularly in Black patients. Traditional CAD risk factors like hypertension (HTN) are both very common and poorly controlled among Black RA patients. Disparities in RA disease activity further increase the risk of CAD in this population. Black patients face significant barriers when seeking RA care, and the investigators suspect similar challenges affect HTN care in this population. The goals of this project are to identify and address barriers to HTN care in patients with RA to reduce disparities in HTN and CAD outcomes for Black RA patients. Interviews with Black RA patients, rheumatology providers, and primary care providers in the Duke University Health System will be conducted to describe barriers to HTN care in Black RA patients. Interviews will focus on access to care, patient-provider communication, coordination of care, and the challenges of managing HTN in patients with RA. These interviews will help us to develop an intervention that will focus on improving uncontrolled HTN in Black RA patients. The investigators plan to do this by empowering Black RA patients to actively participate in their HTN care, improving patient-provider communication, and improving coordination between primary care and rheumatology providers. If successful, our intervention has the potential to reduce rates of CAD and associated death for Black RA patients.

NCT ID: NCT05760885 Not yet recruiting - Stroke Clinical Trials

Multisensory Augmentation for Post-stroke Standing Balance

MAB
Start date: October 1, 2024
Phase: Early Phase 1
Study type: Interventional

Many individuals who experience a stroke have problems with their balance. In part, these balance problems may be due to sensory issues. This study will test whether sensory augmentation has the potential to improve post-stroke balance. Sensory augmentation is a method by which non-invasive vibration is used to enhance the sensory information available to users, which may make it easier to feel where they are and prevent losses of balance.

NCT ID: NCT05759299 Not yet recruiting - Clinical trials for Airway Complication of Anesthesia

International obServational sTudy on AiRway manaGement in operAting Room and Non-operaTing Room anaEsthesia

STARGATE
Start date: December 2023
Phase:
Study type: Observational

According to WHO, more than 230 million major surgical procedures are carried out under general anaesthesia each year worldwide. Despite important technological advances, airway management remains a major challenge in anaesthesiology. Data from large perspective studies on current incidence of major peri-intubation adverse events are lacking in the anaesthesia setting, especially on outcomes such as peri-intubation cardiovascular collapse, severe hypoxemia, and cardiac arrest. These events are more common in case of difficulties with airway management so that first pass intubation failure significantly increase the risks. Moreover, it has been documented that even transient hypotension during general anaesthesia, may have long-term consequences and may be associated with a worse outcome in patients undergoing non-cardiac surgery. The primary aim of the study is to assess the current incidence of major peri-intubation adverse events during anaesthesia in patients undergoing elective or emergency surgery and in the setting of nonoperating room anesthesia. The secondary aim is to assess the current practice of airway management during anesthesia worldwide. STARGATE Study will be a large international observational study recruiting all consecutive adult (≥ 18 years old) patients undergoing general anesthesia in operating room and outside operating room. Primary outcome will be a composite of cardiovascular collapse, cardiac arrest and severe hypoxemia.

NCT ID: NCT05756985 Not yet recruiting - Glioblastoma Clinical Trials

Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue

Start date: June 2024
Phase:
Study type: Observational

To collect and preserve glioblastoma tissue during standard of care tumor resection surgery and blood for future molecular and genetic testing. Tissue for research will be collected from three different regions within the same tumor to study how these regions differ in their structure, DNA, and RNA and also to compare the data obtained from this testing to imaging data found in the medical record. The goal of this study is to help us better understand what the glioblastoma tumor tissue looks like and how it functions. This understanding can lead to new therapies for the treatment of glioblastoma in the future.